DDL 2026

We’re excited to be a sponsor of DDL (Drug Delivery to the Lungs) 2026 and we look forward to meeting you in Edinburgh. Stop by booth 207 to learn how our team can support the development of your inhaled product.

Our GMP Quick Start Platform is an early-phase platform-based approach. Ask for more details at the booth.

POSTER

Investigating of the Impact of Flow Rate Acceleration on Dose Aerosolization and Metered Aerodynamic Particle Size Distribution Using Two Dry Powder Inhalers of Differing Device Resistances

Ian Carter, Thermo Fisher Scientific – co-author
Pablo Hale, Thermo Fisher Scientific — co-author
Prior PLM Medical and Inhalytic Ltd. – contributors

Overview
High-speed X-Ray videography and subsequent in silico modeling enable the fundamental elucidation of the dose aerosolization process from a DPI device subjected to varying SS air flows and transient ramp rates. The in silico modeling elucidates the importance of the particle/device collision energy, which derives from the flow ramp rate. From these findings, control of transient ramp rates may be of benefit or even essential for DPI APSD characterizations that indicate realistic patient dosing.